New Leadership at TFRI
Effective August 1st, 2021, Dr. Jim Woodgett, PhD, FRSC, a senior scientist based at the Lunenfeld-Tanenbaum Research Institute (LTRI) at Sinai Health will become the new President and Scientific Director of The Terry Fox Research Institute (TFRI).
Dr. Woodgett is an internationally renowned biologist at the LTRI conducting research in cell signalling and transduction pathways in cancer, diabetes and neurological diseases and was Director of the Institute for 15 years. In addition, he is an advocate for increasing public support for science and medical research and is known for his science communication and public science outreach.
Dr. Woodgett succeeds TFRI’s founding president Dr. Victor Ling, O.C., O.B.C., PhD who has led the Institute since its creation in 2007. For more, see https://www.tfri.ca/updates/news/news-item/distinguished-toronto-scientist-dr-jim-woodgett-takes-up-leadership-of-terry-fox-research-institute-on-august-1.

The Canadian Partnership Against Cancer is calling on partners in health care and communities across Canada to end cervical cancer in Canada by 2040. The Partnership is leading the development and implementation of a Canadian plan to achieve the World Health Organization (WHO)’s eliminatio...
The CCRA biennial awards recognize individuals who have made a remarkable impact on cancer research and the cancer research community. We are pleased to announce the five 2019 awardees: